Clinical Trial Update: A Phase Ib/2 Clinical Study of Fruquintinib Combined With Paclitaxel in the Treatment of Advanced Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase Ib/2 trial evaluating Fruquintinib in combination with Paclitaxel for advanced gastric cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Hutchison Medipharma Limited | Conditions: Gastric Cancer | Phase 1, Phase 2 | Status: COMPLETED